Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cafedrin/Theodrenalin (Akrinor®) Versus Ephedrine for Treatment of Hypotension in the Peri-operative Phase in Inpatient Setting: a Multicenter, Prospective, Non-interventional Study

NCT02893241 is registered in ClinicalTrials.gov with Ratiopharm GmbH as lead sponsor.

NCT NCT02893241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02893241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cafedrin/Theodrenalin (Akrinor®) Versus Ephedrine for Treatment of Hypotension in the Peri-operative Phase in Inpatient Setting: a Multicenter, Prospective, Non-interventional Study
Lead sponsor
Ratiopharm GmbH
Phase
Observational
Overall status
Completed
Start date
April 30, 2016
Completion date
December 31, 2017
Enrollment
2,013 (actual)
Sites
75

Conditions

As the registry lists them; a condition with its own page is linked.

hypotension